Avience Biomedicals (NSE:AVIENCE) Total Equity: ₹285.2 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Total Equity?

Avience Biomedicals NSE:AVIENCE 5 Total Equity is ₹285.2 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's total equity for the quarter that ended in Jan. 2026 was ₹285.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Avience Biomedicals Total Equity Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Total Equity Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Total Equity
40.70 62.11 227.77

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Total Equity 40.70 62.11 227.77 285.17
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Avience Biomedicals's Total Equity for the fiscal year that ended in Mar. 2025 is calculated as

Total Equity=Total Assets(Q: Mar. 2025 )-Total Liabilities(Q: Mar. 2025 )
=565.246-337.475
=227.8

Avience Biomedicals's Total Equity for the quarter that ended in Jan. 2026 is calculated as

Total Equity=Total Assets(Q: Jan. 2026 )-Total Liabilities(Q: Jan. 2026 )
=660.72-375.553
=285.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹285.2 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Total Equity of ₹285.2 Mil as of Jan. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Avience Biomedicals and its competitors.
Is Avience Biomedicals' Total Equity too high?
Avience Biomedicals' current Total Equity is ₹285.2 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Total Equity compare to ABT and SYK?
Avience Biomedicals' Total Equity of ₹285.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Avience Biomedicals and its competitors. Avience Biomedicals's current Total Equity is ₹285.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Total Equity of ₹285.2 Mil. The current Total Equity is ₹285.2 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Total Equity is ₹285.2 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price